Serimmune Inc.
Goleta, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
PD
Patrick DaughertyFounder
KL
Kristin LoomisNamed on SEC filing
BW
Bill WelchNamed on SEC filing
NN
Nick NaclerioNamed on SEC filing
JS
John ShonNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$27.5M disclosed across 4 rounds · 2016–2023
▶$11.5MraisedNov 2023 · 2 investors · BiotechnologyRule 506(b)
▶$11.5MraisedNov 2023 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Malek FahamExecutive Officer, Director
- Kirstin LoomisDirector
- Nicholas NaclerioDirector
- Bill WelchDirector
- Offering amount
- $16.5M
- Amount sold
- $11.5M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12MraisedSep 2020 · 7 investors · BiotechnologyRule 506(b)
▶$12MraisedSep 2020 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen M. KujawaExecutive Officer
- Kristin LoomisDirector
- Nicholas NaclerioDirector
- Noah NasserExecutive Officer, Director
- Patrick DaughertyExecutive Officer, Director
- Jaymie R. SawyerExecutive Officer
- John ShonExecutive Officer
- Bill WelchDirector
- Offering amount
- $23.3M
- Amount sold
- $12M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedJun 2019 · 5 investors · BiotechnologyRule 506(b)
▶$1.4MraisedJun 2019 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kristin LoomisDirector
- Bill WelchDirector
- Nick NaclerioDirector
- Patrick DaughertyExecutive Officer, Director
- John ShonExecutive Officer
- Offering amount
- $7M
- Amount sold
- $1.4M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedJan 2017 · 7 investors · BiotechnologyRule 506(b)
▶$2.5MraisedJan 2017 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kristin LoomisExecutive Officer, Director
- Patrick DaughertyExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $2.5M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Serimmune Inc. went on to found or lead other companies.
Frequently asked questions
- Who founded Serimmune Inc.?
- Serimmune Inc. was founded by Patrick Daugherty.
- Who are Serimmune Inc.'s investors?
- Serimmune Inc.'s investors include Illumina Innovation.
- How much funding has Serimmune Inc. raised?
- Serimmune Inc. has disclosed $27.5M raised across 4 rounds.
- Where is Serimmune Inc. headquartered?
- Serimmune Inc. is headquartered in Goleta, US.